Optimising the use of the prostate-specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.
作者信息
Takahashi Takeshi
机构信息
Public Health Physician, ex-Urologic Surgeon, Health and Welfare Bureau, Kitakyushu City, Kyushu, Japan. Email:
出版信息
Br J Gen Pract. 2024 Aug 29;74(746):397. doi: 10.3399/bjgp24X739197. Print 2024 Sep.
Abstract
摘要
相似文献
1
Optimising the use of the prostate-specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.优化在初级保健中对无症状男性使用前列腺特异性抗原血液检测以早期发现前列腺癌：来自英国临床共识的报告
Br J Gen Pract. 2024 Aug 29;74(746):397. doi: 10.3399/bjgp24X739197. Print 2024 Sep.
2
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.优化在无症状男性中使用前列腺特异性抗原血液检测进行早期前列腺癌筛查的策略：来自英国临床共识的报告。
Br J Gen Pract. 2024 Jul 25;74(745):e534-e543. doi: 10.3399/BJGP.2023.0586. Print 2024 Aug.
3
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3.
4
Prostate Cancer Mortality in Men Aged 70 Years Who Recently Underwent Prostate-Specific Antigen Screening.近期接受前列腺特异性抗原筛查的70岁男性的前列腺癌死亡率
JAMA Netw Open. 2025 Feb 3;8(2):e2459766. doi: 10.1001/jamanetworkopen.2024.59766.
5
Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.基于前列腺特异性抗原（PSA）的前列腺癌群体筛查：一项循证分析。
Ont Health Technol Assess Ser. 2015 May 1;15(10):1-64. eCollection 2015.
6
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.用前列腺特异性抗原检测进行前列腺癌筛查：当前证据回顾。
JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085.
7
American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.美国泌尿外科学会 (AUA) 前列腺癌检测指南：流程和原理。
BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318.
8
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.美国黑人男性前列腺癌基金会筛查指南
NEJM Evid. 2024 May;3(5):EVIDoa2300289. doi: 10.1056/EVIDoa2300289. Epub 2024 Apr 23.
9
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer.多基因风险评分在前列腺癌筛查中的评估
N Engl J Med. 2025 Apr 10;392(14):1406-1417. doi: 10.1056/NEJMoa2407934.
10
Prostate cancer screening in Switzerland: a literature review and consensus statement from the Swiss Society of Urology.瑞士的前列腺癌筛查：瑞士泌尿外科学会的文献回顾和共识声明。
Swiss Med Wkly. 2024 May 31;154:3626. doi: 10.57187/s.3626.
引用本文的文献
1
Urologists and pathologists in prostate cancer screening.前列腺癌筛查中的泌尿科医生和病理学家。
Virchows Arch. 2024 Sep 21. doi: 10.1007/s00428-024-03929-y.
本文引用的文献
1
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.优化在无症状男性中使用前列腺特异性抗原血液检测进行早期前列腺癌筛查的策略：来自英国临床共识的报告。
Br J Gen Pract. 2024 Jul 25;74(745):e534-e543. doi: 10.3399/BJGP.2023.0586. Print 2024 Aug.
2
Determining the clinical significance of pathological findings in prostate cancer.确定前列腺癌病理结果的临床意义。
Virchows Arch. 2024 Apr 11. doi: 10.1007/s00428-024-03804-w.
3
Two conflicting guidelines on prostate specific antigen screening in Japan.日本关于前列腺特异性抗原筛查的两项相互矛盾的指南。
Jpn J Clin Oncol. 2023 Mar 7;53(3):280-283. doi: 10.1093/jjco/hyac192.
4
Progress and problems in screening for carcinoma of the prostate.前列腺癌筛查的进展与问题
World J Surg. 1989 Jan-Feb;13(1):60-4. doi: 10.1007/BF01671155.
Zotero 插件